Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by CancerSlayer

V.TLT

RE:Roche withdraws immunotherapy Drug for Bladder Cancer

  SF...thanks & I have to applaud your extensive & timely DD. ...

January 4, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:9 more sites

Donein25 wrote: Infinity, your thoughts on first line treatment caught my...

January 4, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:9 more sites

Eoganacht wrote: I think the big tests after the bladder cancer treatment is...

January 4, 2023

V.TLT

RE:RE:RE:RE:RE:9 more sites

enriquesuave wrote: I just checked and see that Endocyte buyout happened in...

January 4, 2023

V.TLT

RE:9 more sites

Per the article: "We are approximately halfway through enrollment, with...

January 3, 2023

V.TLT

RE:RE:RE:Makes sense

CancerSlayer wrote: Oilminerdeluxe wrote: Dr. Mandel also notes that the...

January 3, 2023

V.TLT

RE:RE:Makes sense

Oilminerdeluxe wrote: Dr. Mandel also notes that the company expects to...

January 3, 2023

V.TLT

RE:Vaccine Platform

enriquesuave wrote: If successful, the vaccine platform could be a game...

December 31, 2022

V.TLT

RE:RE:RE:RE:RE:what's the deal

Other than the usual shenanigans of professional traders & your random...

December 30, 2022

V.TLT

RE:RE:RE:RE:RE:RE:Very Good News!

enriquesuave wrote: Misleading on Press release, but it seems 23.5% of...

December 19, 2022

V.TLT

RE:RE:FDA’s comment

Good point SF....& this viral-vector gene therapy not only has more...

December 17, 2022

V.TLT

RE:RE:RE:RE:Very Good News!

DJDawg wrote: I was curious about the drop off in CR over time. I couldn'...

December 16, 2022

V.TLT

RE:RE:RE:RE:RE:Here's what I'M THINKING----

Nice post skys1... However, I look at value from a different perspective. ...

December 15, 2022

V.TLT

RE:McFarland Research Group Perfecting Potent Osmium PS ML18J03

Interesting abstract....thanks for sharing. These newer generation metal...

December 11, 2022

V.TLT

RE:Accelerated Approval - what are the chances?

  Thanks Eoganacht....Uddin certainly needs to do more homework next...

December 8, 2022

V.TLT

RE:RE:5y follow-up of Keytruda in NMIBC BCG-Unresponsive

That makes two of us Dawg...the data seem to indicate very little benefit...

December 7, 2022

V.TLT

RE:2 weeks: It’s all it took for Merck to get AA

ScienceFirst wrote: 2 weeks! It's all it took for the FDA to grant...

December 7, 2022

V.TLT

RE:The perfect example of Accelerated Approval

ScienceFirst wrote: DeathXray33 ... The perfect example of the benefit of the...

December 4, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CG Oncology NMIBC data

No problem Apophis...glad at least you were entertained.   A small...

December 4, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CG Oncology NMIBC data

99942Apophis wrote:   CancerSlayer wrote:   Well...

December 4, 2022

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

SKRR Exploration Inc.

SKRR Exploration Inc. V.SKRR

SKRR Exploration Inc. is a Canada-based precious and base metal explorer with properties in Saskatchewan. The Company's ... view more »